1-5 of 5
Hari Miskin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Acalabrutinib, Umbralisib and Ublituximab Regimen (AU2) Demonstrates High Response Rate and Undetectable Molecular Minimal Residual Disease (MRD) in Patients (pts) with De Novo Mantle Cell Lymphoma (MCL)

Free
Paolo Lopedote, Geoffrey Shouse, Alexandra Muir, Carly Rolender, Peter Sportelli, Hari Miskin, Lu Chen, Tycel Phillips, Alexey Danilov
Journal: Blood
Blood (2024) 144 (Supplement 1): 1633.
https://doi.org/10.1182/blood-2024-200963
Published: 2024
Journal Articles

A Phase I Dose Escalation Study Of TGR-1202, a Novel PI3K-δ Inhibitor, For Patients With Relapsed Or Refractory Hematologic Malignancies

Free
Michael Savona, MD, Martin Gutierrez, MD, Mark Lanasa, MD, PhD, Changchun Deng, MD, PhD, John Kuhn, PharmD, Lauren Sade, Hari Miskin, MS, Peter Sportelli, Swaroop Vakkalanka, PhD, Manish Patel, MD
Journal: Blood
Blood (2013) 122 (21): 4373.
https://doi.org/10.1182/blood.V122.21.4373.4373
Published: 2013
Journal Articles

Novel PI3K Inhibitors Demonstrated Marked Cytotoxicity in T Cell Lymphoma Models, Caused Apoptosis and Were Synergistic with A Novel Anti-CD20 Monoclonal Antibody Ublituximab in B Cell Lymphoma Models

Free
Changchun Deng, MD, PHD, Peter Sportelli, Richard Rodriguez, Hari Miskin, Swaroop Vakkalanka, Srikant Viswanadha, Owen A. O'Connor, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 3725.
https://doi.org/10.1182/blood.V120.21.3725.3725
Published: 2012
Journal Articles

TGR-1202: A Novel, Targeted PI3Kδ Inhibitor in Multiple Myeloma

Free
Swaroop Vakkalanka, Srikant Viswanadha, Lawrence H. Boise, PhD, Peter Sportelli, Hari Miskin, Sagar Lonial, MD
Journal: Blood
Blood (2012) 120 (21): 5018.
https://doi.org/10.1182/blood.V120.21.5018.5018
Published: 2012
Journal Articles

Comparison of the PI3K-δ Inhibitors TGR1202 and GS-1101 in Inducing Cytotoxicity and Inhibiting Phosphorylation of Akt in CLL Cells in Vitro

Free
Daphne R. Friedman, M.D., Mark C. Lanasa, MD, PhD, Danielle M. Brander, MD, Sallie D. Allgood, MS, Evan D. Davis, BS, Hari Miskin, Srikant Viswanadha, Swaroop Vakkalanka, J. Brice Weinberg, MD
Journal: Blood
Blood (2012) 120 (21): 3914.
https://doi.org/10.1182/blood.V120.21.3914.3914
Published: 2012